About Us

ReGen Biologics believes that maintaining a physically active lifestyle is the key to long-term vitality.  As an orthopedic products company, ReGen provides minimally invasive implants and medical devices designed to facilitate new tissue growth to replace damaged or removed soft tissue. ReGen helps people regain mobility and return to a more vigorous lifestyle after sustaining torn or damaged meniscus cartilage.  ReGen's Menaflex™ collagen meniscus implant (formerly CMI^®) is a biologically-derived device engineered to guide new meniscus tissue formation and return the patient to a more active lifestyle.

ReGen Biologics is an orthopedic company that develops, manufactures, and markets innovative tissue growth and repair products for the sports medicine market worldwide.  The company’s patented cell guiding collagen scaffold technology includes applications in orthopedics, general surgery, spine, cardiovascular, and drug delivery.

Founded in 1990, ReGen is headquartered in Hackensack, New Jersey, and operates an ISO 13485 certified manufacturing facility in Redwood City, California. ReGen's biological remodeling scaffold can be applied to a variety of therapeutic applications.   The Company continues to develop and introduce tissue regrowth products based on its patented technologies.

ReGen's flagship product, Menaflex, is focused in orthopaedics. The Menaflex has been cleared for sale in Europe and Africa.  ReGen has completed enrollment and surgeries for a major Multicenter Clinical Trial in the United States. Two year and five year follow-up results from the Feasibility Study show decreased pain levels, increased activity levels and increased meniscus volume.  The five year follow-up shows a continuation of the trends reported at two years.  The five year Feasability Study results have been published by the journal Arthroscopy.  Based on these controlled studies, Menaflex has been proven safe and effective by the lack of clinically significant complications.

ReGen also sells the SharpShooter® Tissue Repair System, an arthroscopic device used for meniscus repair procedures, through a distribution agreement with Linvatec, a division of CONMED Corporation (NASDAQ: CNMD).

Mission Statement
ReGen's mission is to become the world's orthopedic technology leader in products that facilitate the growth of soft tissue by enhancing the body's natural healing process.  Our aim is to develop and market products that support tissue generation, restore mobility and rejuvenate lifestyles in injured patients.